Muhs Bart E, Gagne Paul, Plitas George, Shaw Jason P, Shamamian Peter
S. A. Localio Laboratory for Surgical Research, New York University School of Medicine, 530 First Avenue, Suite 6F, New York, NY 10016, USA.
J Surg Res. 2004 Apr;117(2):249-54. doi: 10.1016/j.jss.2003.09.009.
Matrix metalloproteinases (MMP)-2 and -9 are Type 4 collagenases instrumental in basement membrane degradation, a process necessary for angiogenesis to occur. Polymorphonuclear leukocytes (PMNs) contain MMP-9, and in the presence of both PMN-derived serine protease and membrane type 1 (MT1)-MMP, are able to activate pro-MMP-2 following hindlimb ischemia. We hypothesized that neutrophil depletion (ND) of animals prior to hindlimb ischemia (HI) would abrogate the activation of pro-MMP-2 and decrease the level of MMP-9
12 FVB/N Tie2/LacZ-182 SATO female mice were randomly divided into four blinded groups; HI + PBS, HI + anti-PMN antibody (GR-1), HI + isotype matched control antibody (IgG(2b,K)), and no HI + PBS. PMN depletion was achieved prior to the time of ischemia and maintained until sacrifice. HI was achieved by unilateral femoral artery ligation. Three days postligation the animals were sacrificed and the gastrocnemius muscle from each hindlimb was harvested. MMP-2 and -9 (gelatin zymography) and MT1-MMP (Western blot) expression and activation were quantified by densitometry and NIH Image Analysis software. MMP values were expressed as a ratio of ischemic-to-nonischemic hindlimbs and compared between groups. Statistical significance was determined with analysis of variance (ANOVA) RESULTS: Zymograms revealed a greater than 10-fold increase in active MMP-9 and greater than 4-fold increase in active MMP-2 from HI + PBS compared to no HI + PBS (P < 0.05). HI + anti-PMN antibody demonstrated reduction of both active MMP-2 and -9 levels to that of the nonischemic group. Pro-MMP-2 was constitutively expressed in all four groups with no significant differences between any group (P = NS). There was no difference between the HI + isotype-matched antibody group and the HI + PBS group throughout the experiments (P = NS). ND did not affect MT1-MMP activation or expression
Limb ischemia causes activation of MMP-2 and -9, which is eliminated by ND. ND animals undergoing hindlimb ischemia exhibit identical levels of active MMP-2 and -9 as animals that did not have hindlimb ischemia. Neutrophils may be an important activator of MMP-2 and the suppliers of MMP-9 in the ischemic hindlimb and may be essential for tissue remodeling, basement membrane degradation, and angiogenesis in ischemic limbs
基质金属蛋白酶(MMP)-2和-9是IV型胶原酶,对基底膜降解起重要作用,而基底膜降解是血管生成所必需的过程。多形核白细胞(PMN)含有MMP-9,在PMN衍生的丝氨酸蛋白酶和膜型1(MT1)-MMP共同存在的情况下,后肢缺血后能够激活前MMP-2。我们假设在进行后肢缺血(HI)之前对动物进行中性粒细胞清除(ND)会消除前MMP-2的激活并降低MMP-9的水平。
12只FVB/N Tie2/LacZ-182 SATO雌性小鼠被随机分为四个盲法组;HI + PBS组、HI +抗PMN抗体(GR-1)组、HI +同型匹配对照抗体(IgG(2b,K))组和无HI + PBS组。在缺血前实现中性粒细胞清除并维持至处死。通过单侧股动脉结扎实现后肢缺血。结扎后三天处死动物,收集每个后肢的腓肠肌。通过光密度测定法和NIH图像分析软件对MMP-2和-9(明胶酶谱法)以及MT1-MMP(蛋白质印迹法)的表达和激活进行定量。MMP值表示为缺血后肢与非缺血后肢的比值,并在组间进行比较。采用方差分析(ANOVA)确定统计学意义。
酶谱分析显示,与无HI + PBS组相比,HI + PBS组中活性MMP-9增加超过10倍,活性MMP-2增加超过4倍(P < 0.05)。HI +抗PMN抗体组的活性MMP-2和-9水平均降低至非缺血组水平。前MMP-2在所有四组中均组成性表达,任何组之间均无显著差异(P =无显著性差异)。在整个实验过程中,HI +同型匹配抗体组和HI + PBS组之间无差异(P =无显著性差异)。中性粒细胞清除不影响MT1-MMP的激活或表达。
肢体缺血导致MMP-2和-9的激活,而中性粒细胞清除可消除这种激活。经历后肢缺血的中性粒细胞清除动物的活性MMP-2和-9水平与未经历后肢缺血的动物相同。中性粒细胞可能是缺血后肢中MMP-2的重要激活剂和MMP-9的供应者,可能对缺血肢体的组织重塑、基底膜降解和血管生成至关重要